Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00961493
NCT00961493CompletedNot Applicable

Randomized Controlled Trial of an Acceptance-based Behavior Therapy for Generalized Anxiety Disorder

University of Massachusetts, Boston2 sites in 1 country81 target enrollmentStarted: March 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
81
Locations
2
Primary Endpoint
Hamilton Anxiety Rating Scale
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to determine whether acceptance-based behavior therapy for GAD results in greater symptom reduction and increased quality of life than applied relaxation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •principal diagnosis of GAD
  • •at least moderate (4 on a scale from 0 to 8) on the ADIS Severity Scale for GAD symptoms
  • •willing to maintain current psychotropic medication levels (and have been stabilized on any current medications for at least three months) and refrain from other psychosocial treatments for anxiety or mood problems during the course of therapy
  • •fluent in English
  • •18 years or older

Exclusion Criteria

  • •bipolar disorder
  • •psychotic disorders
  • •substance dependence
  • •active suicidal intent
  • •if anxious symptomatology is due to a medical/physical condition

Outcomes

Primary Outcomes

Hamilton Anxiety Rating Scale

Time Frame: pre-treatment, post-treatment, and 6-, 12-, and 24-month follow-up

Anxiety Disorders Interview Schedule for DSM-IV, Clinician Severity Rating of GAD

Time Frame: pre-treatment, post-treatment, and 6-, 12-, and 24-month follow-up

Penn State Worry Questionnaire

Time Frame: pre-treatment, post-treatment, and 6-, 12-, and 24-month follow-up

Secondary Outcomes

  • Beck Depression Inventory - II(pre-treatment, post-treatment, and 6-, 12-, and 24-month follow-up)
  • Quality of Life Inventory(pre-treatment, post-treatment, and 6-, 12-, and 24-month follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lizabeth Roemer

Professor of Psychology

University of Massachusetts, Boston

Study Sites (2)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset PsychosisEarly PsychosisPsychotic Disorders
NCT06192602Chinese University of Hong Kong126
Completed
Not Applicable
The Effect of Acceptance and Commitment TherapyAutism, Infantile
NCT04909658S.Anna Rehabilitation Institute66
Recruiting
Not Applicable
ACT for Parents of Children With Neurodevelopmental ComorbiditiesAsthma in ChildrenAttention Deficit Hyperactivity Disorder
NCT04991649Chinese University of Hong Kong118
Completed
Phase 1
Acceptance-Based Treatment for Generalized Anxiety DisorderAnxiety DisordersGeneralized Anxiety Disorder
NCT00073632University of Massachusetts, Boston50
Completed
Not Applicable
Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical ActivitySchizophrenia Spectrum and Other Psychotic Disorders
NCT04916496Chinese University of Hong Kong72